2m 2m 2m 2m 2m 2m 2m
TRINITY BIO SP ADR (TRIB)
NASDAQ
$0.71+$0.004 (+0.58%)
Price as of Jun 03, 2026 7:56 PM EDT- $14.2MMarket Cap
- 7.85%1-Year Change
- Medical DevicesIndustry
TRINITY BIO SP ADR (TRIB)
$0.71+$0.004 (+0.58%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 43.8M -28.87% | 61.6M +8.31% | 56.8M -24.00% | 74.8M -19.56% | |
Cost of Revenue | 26.9M -32.95% | 40.1M +7.31% | 37.4M -29.11% | 52.7M -3.93% | |
Gross Profit | 16.9M -21.24% | 21.4M +10.24% | 19.4M -11.78% | 22.0M -42.10% | |
Sales and Marketing Expense | 24.7M -14.37% | 28.8M -7.50% | 31.2M +6.81% | 29.2M +18.16% | |
Research and Development Expense | -3.6M -20.12% | -4.5M +3.75% | -4.4M +5.82% | -4.1M -7.98% | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 24.7M -14.37% | 28.8M -7.50% | 31.2M +6.81% | 29.2M +18.16% | |
Operating Profit | -15.8M -25.40% | -21.2M -21.74% | -27.0M +61.44% | -16.8M -352.86% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 0 -100.00% | 40,000 -71.01% | 138,000 N/A | 0 N/A | |
Income before Taxes | 1.9M +106.12% | -31.2M -15.33% | -36.9M -10.08% | -41.0M -4,513.56% | |
Income Taxes | 199,000 -59.05% | 486,000 +923.73% | -59,000 -69.27% | -192,000 +7.87% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 1.9M +106.12% | -31.2M -15.33% | -36.9M -10.08% | -41.0M -4,513.56% | |
Net Income from Continuing Operations Applicable to Common | 1.9M +106.12% | -31.2M -15.33% | -36.9M -10.08% | -41.0M -4,513.56% | |
Basic EPS and Net Income | -2.00 +12.99% | -1.77 -46.36% | -3.30 +117.11% | -1.52 -3,140.00% | |
Diluted EPS and Net Income | -2.00 +12.99% | -1.77 -46.36% | -3.30 +117.11% | -1.52 -3,140.00% | |
Basic Weighted Average Shares | 371.5M +3.43% | 359.2M +134.61% | 153.1M +13.46% | 134.9M +61.40% | |
Diluted Weighted Average Shares | 371.5M +3.43% | 359.2M +134.61% | 153.1M +13.46% | 134.9M +61.40% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 5.1M -0.56% | 5.2M +39.99% | 3.7M -43.89% | 6.6M -74.61% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 5.1M -0.56% | 5.2M +39.99% | 3.7M -43.89% | 6.6M -90.72% | |
Total Current Assets | 35.9M -12.70% | 41.1M +5.34% | 39.0M -16.34% | 46.7M -35.80% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 5.3M +14.74% | 4.6M +144.24% | 1.9M -66.70% | 5.7M -3.99% | |
Total Long-Term Assets | 69.3M +11.42% | 62.2M +204.82% | 20.4M -55.11% | 45.4M -1.67% | |
Total Assets | 105.2M +1.82% | 103.3M +73.79% | 59.4M -35.47% | 92.1M -22.53% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 141.2M +339.97% | 32.1M +113.47% | 15.0M -13.29% | 17.3M -82.75% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 31,000 N/A | |
Total Long-Term Liabilities | 35.9M -66.22% | 106.4M +55.64% | 68.3M -11.17% | 76.9M +310.94% | |
Total Liabilities | 177.1M +27.93% | 138.5M +66.06% | 83.4M -11.56% | 94.3M -20.92% | |
Retained Earnings | -116.2M +46.83% | -79.1M +62.64% | -48.6M +82.22% | -26.7M -312.56% | |
Total Stockholders Equity | -72.0M +104.60% | -35.2M +46.90% | -23.9M +1,000.60% | -2.2M +582.13% | |
Total Shares Outstanding | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash Flow | |||||
Cash from Operating Activities | -5.9M +41.47% | -4.2M -63.74% | -11.6M +1,154.83% | -921,000 -106.96% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -6.2M -72.91% | -23.0M -192.78% | 24.8M +514.19% | -6.0M -31.23% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 12.1M -58.17% | 28.8M +279.59% | -16.0M +30.19% | -12.3M +104.72% | |
Financials Ratio | |||||
Gross Margin | 38.57% +10.72% | 34.83% +1.78% | 34.22% +16.07% | 29.48% -28.01% | |
Operating Margin | -36.06% +4.88% | -34.38% -27.75% | -47.59% +112.43% | -22.40% -414.36% | |
Return on Assets | 1.83% +104.78% | -38.37% -21.15% | -48.66% +25.20% | -38.86% -5,314.62% | |
Return on Equity | -3.57% -103.38% | 105.58% -62.59% | 282.24% -91.41% | 3,286.73% +4,589.63% | |
Revenue Growth | -28.87% -447.37% | 8.31% +134.63% | -24.00% +22.69% | -19.56% +121.29% | |
Current Ratio | 0.25 -80.16% | 1.28 -50.66% | 2.60 -3.52% | 2.69 +272.11% | |
Cash Ratio | 0.04 -77.39% | 0.16 -34.42% | 0.25 -35.29% | 0.38 +47.17% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow